Mada Shinta Dewi, country manager at Mundipharma Indonesia, explains the unique business model of Mundipharma in Indonesia, collaboration with the local business community, and the benefits that the company’s consumer health medicines and ethical business line can bring to patients.
Could you please explain to our international audience how the operations of Mundipharma have evolved in Indonesia?
"In 2012, we decided to open a representative office in Indonesia because of the high dynamism of the national regulatory environment as well as our corporate guideline of being closer to those countries where our products are marketed."
